Efficacy and safety of dabigatran for venous thrombosis prophylaxis after knee replacement surgery in Thai patients: a prospective non-randomized controlled trial

[1]Stulberg BN, Insall JN, Williams GW, Ghelman B. Deep-vein thrombosis following total knee replacement. An analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg Am. 1984; 66:194–201.StulbergBNInsallJNWilliamsGWGhelmanBDeep-vein thrombosis following total knee replacement. An analysis of six hundred and thirty-eight arthroplastiesJ Bone Joint Surg Am19846619420110.2106/00004623-198466020-00005Search in Google Scholar

[2]Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141:e278S–e325S.Falck-YtterYFrancisCWJohansonNACurleyCDahlOESchulmanSPrevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest2012141e278Se325S10.1378/chest.11-2404327806322315265Search in Google Scholar

[3]Bin Abd Razak HR, Soon AT, Dhanaraj ID, Tan AH. Incidence of clinically significant venous thromboembolic events in Asian patients undergoing total knee arthroplasty without anticoagulation. J Arthroplasty. 2012; 27:1128–32.Bin Abd RazakHRSoonATDhanarajIDTanAHIncidence of clinically significant venous thromboembolic events in Asian patients undergoing total knee arthroplasty without anticoagulationJ Arthroplasty20122711283210.1016/j.arth.2011.09.02422088783Search in Google Scholar

[4]Kim YH, Kim JS. Incidence and natural history of deep-vein thrombosis after total knee arthroplasty. A prospective, randomised study. J Bone Joint Surg Br. 2002; 84:566–70.KimYHKimJSIncidence and natural history of deep-vein thrombosis after total knee arthroplasty. A prospective, randomised studyJ Bone Joint Surg Br2002845667010.1302/0301-620X.84B4.0840566Search in Google Scholar

[5]Ko PS, Chan WF, Siu TH, Khoo J, Wu WC, Lam JJ. Deep venous thrombosis after total hip or knee arthroplasty in a low-risk Chinese population. J Arthroplasty. 2003; 18:174–9.KoPSChanWFSiuTHKhooJWuWCLamJJDeep venous thrombosis after total hip or knee arthroplasty in a low-risk Chinese populationJ Arthroplasty200318174910.1054/arth.2003.5004012629607Search in Google Scholar

[6]Leizorovicz A, Committee SVSS (SMART Venography Study Steering Committee). Epidemiology of post-operative venous thromboembolism in Asian patients. Results of the SMART venography study. Haematologica. 2007; 92:1194–200.LeizoroviczACommittee SVSS (SMART Venography Study Steering Committee)Epidemiology of post-operative venous thromboembolism in Asian patients. Results of the SMART venography studyHaematologica200792119420010.3324/haematol.1081917666370Search in Google Scholar

[7]Won MH, Lee GW, Lee TJ, Moon KH. Prevalence and risk factors of thromboembolism after joint arthroplasty without chemical thromboprophylaxis in an Asian population. J Arthroplasty. 2011; 26:1106–11.WonMHLeeGWLeeTJMoonKHPrevalence and risk factors of thromboembolism after joint arthroplasty without chemical thromboprophylaxis in an Asian populationJ Arthroplasty20112611061110.1016/j.arth.2010.11.00521256698Search in Google Scholar

[8]Friedman RJ, Dahl OE, Rosencher N, Caprini JA, Kurth AA, Francis CW, et al. Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res. 2010; 126:175–82.FriedmanRJDahlOERosencherNCapriniJAKurthAAFrancisCWDabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trialsThromb Res20101261758210.1016/j.thromres.2010.03.02120434759Search in Google Scholar

[9]Fuji T, Fuijita S, Ujihira T, Sato T. Dabigatran etexilate prevents venous thromboembolism after total knee arthroplasty in Japanese patients with a safety profile comparable to placebo. J Arthroplasty. 2010; 25:1267–74.FujiTFuijitaSUjihiraTSatoTDabigatran etexilate prevents venous thromboembolism after total knee arthroplasty in Japanese patients with a safety profile comparable to placeboJ Arthroplasty20102512677410.1016/j.arth.2009.08.01019854610Search in Google Scholar

[10]The European Agency for the Evaluation of Medicinal Products, Committee for Medicinal Products for Human Use (CHMP). Guideline on clinical investigation of medicinal products for prophylaxis of high intra- and post-operative venous thromboembolic risk. [online] 2012. [cited 2012 Mar 15]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-investigation-medicinal-products-prophylaxis-high-intra-post-operative-venous_en.pdf.The European Agency for the Evaluation of Medicinal Products, Committee for Medicinal Products for Human Use (CHMP)Guideline on clinical investigation of medicinal products for prophylaxis of high intra- and post-operative venous thromboembolic risk[online] 2012. [cited 2012 Mar 15]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-clinical-investigation-medicinal-products-prophylaxis-high-intra-post-operative-venous_en.pdf.Search in Google Scholar

[11]Blanchard J, Meuwly JY, Leyvraz PF, Miron MJ, Bounameaux H, Hoffmeyer P, et al. Prevention of deep-vein thrombosis after total knee replacement. Randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump system. J Bone Joint Surg Br. 1999; 81:654–9.BlanchardJMeuwlyJYLeyvrazPFMironMJBounameauxHHoffmeyerPPrevention of deep-vein thrombosis after total knee replacement. Randomised comparison between a low-molecular-weight heparin (nadroparin) and mechanical prophylaxis with a foot-pump systemJ Bone Joint Surg Br199981654910.1302/0301-620X.81B4.0810654Search in Google Scholar

[12]Nathan S, Aleem MA, Thiagarajan P, Das De S. The incidence of proximal deep vein thrombosis following total knee arthroplasty in an Asian population: a Doppler ultrasound study. J Orthop Surg (Hong Kong). 2003; 11:184–9.NathanSAleemMAThiagarajanPDas DeSThe incidence of proximal deep vein thrombosis following total knee arthroplasty in an Asian population: a Doppler ultrasound studyJ Orthop Surg (Hong Kong)200311184910.1177/230949900301100214Search in Google Scholar

[13]Sudo A, Sano T, Horikawa K, Yamakawa T, Shi D, Uchida A. The incidence of deep vein thrombosis after hip and knee arthroplasties in Japanese patients: a prospective study. J Orthop Surg (Hong Kong). 2003; 11:174–7.SudoASanoTHorikawaKYamakawaTShiDUchidaAThe incidence of deep vein thrombosis after hip and knee arthroplasties in Japanese patients: a prospective studyJ Orthop Surg (Hong Kong)200311174710.1177/230949900301100212Search in Google Scholar

[14]Cohen AT, Asia-Pacific Thrombosis Advisory Board. Asia-Pacific Thrombosis Advisory Board consensus paper on prevention of venous thromboembolism after major orthopaedic surgery. Thromb Haemost. 2010; 104:919–30.CohenATAsia-Pacific Thrombosis Advisory BoardAsia-Pacific Thrombosis Advisory Board consensus paper on prevention of venous thromboembolism after major orthopaedic surgeryThromb Haemost20101049193010.1160/TH10-03-0190Search in Google Scholar

[15]Rostagno C. New oral anticoagulants in prophylaxis of venous thromboembolic disease in major orthopedic surgery. Cardiovasc Hematol Disord Drug Targets. 2016; 15:204–9.RostagnoCNew oral anticoagulants in prophylaxis of venous thromboembolic disease in major orthopedic surgeryCardiovasc Hematol Disord Drug Targets201615204910.2174/1871529X16666160101122632Search in Google Scholar

[16]Intiyanaravut T, Thongpulsawasdi N, Sinthuvanich N, Teavirat S, Kunopart M. Enoxaparin versus no anticoagulation prophylaxis after total knee arthroplasty in Thai patients: a randomized controlled trial. J Med Assoc Thai. 2017; 100:42–9.IntiyanaravutTThongpulsawasdiNSinthuvanichNTeaviratSKunopartMEnoxaparin versus no anticoagulation prophylaxis after total knee arthroplasty in Thai patients: a randomized controlled trialJ Med Assoc Thai2017100429Search in Google Scholar

[17]Barnes RW, Nix ML, Barnes CL, Lavender RC, Golden WE, Harmon BH, et al. Perioperative asymptomatic venous thrombosis: role of duplex scanning versus venography. J Vasc Surg. 1989; 9:251–60.BarnesRWNixMLBarnesCLLavenderRCGoldenWEHarmonBHPerioperative asymptomatic venous thrombosis: role of duplex scanning versus venographyJ Vasc Surg198992516010.1016/0741-5214(89)90044-XSearch in Google Scholar

[18]Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ, et al. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost. 2005; 93:76–9.VaitkusPTLeizoroviczACohenATTurpieAGOlssonCGGoldhaberSZMortality rates and risk factors for asymptomatic deep vein thrombosis in medical patientsThromb Haemost20059376910.1160/TH04-05-032315630494Search in Google Scholar

[19]Grady-Benson JC, Oishi CS, Hanson PB, Colwell CW Jr, Otis SM, Walker RH. Postoperative surveillance for deep venous thrombosis with duplex ultrasonography after total knee arthroplasty. J Bone Joint Surg Am. 1994; 76:1649–57.Grady-BensonJCOishiCSHansonPBColwellCWJrOtisSMWalkerRHPostoperative surveillance for deep venous thrombosis with duplex ultrasonography after total knee arthroplastyJ Bone Joint Surg Am19947616495710.2106/00004623-199411000-000087962025Search in Google Scholar